newsfilter
← Latest News
PR Newswire·

Inhibrx Reports Fourth Quarter and Fiscal Year 2025 Financial Results

Inhibrx Biosciences, Inc. (Nasdaq: INBX) ("Inhibrx" or the "Company") today reported financial results for the fourth quarter and fiscal year 2025....